I don't think you'll see an PR with loosey Koosey telling us little peon stockholders the date of the IPO. He would have done it already. But why hasn't he?
Because the REGEN start of trading hinges on HEMA approval for clinical trials and submission of DCellVax IND. Those two are the catalysts to help the REGEN trading get off to a good start. Without those two, REGEN will most likely fall flat if it started to trade due to no catalyst to get people interested.
This has one big cluster plus word that rhymes with buck.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.